Healthcare -
Biotechnology - NYSE - CH
$ 1.635
-7.1 %
$ 158 M
Market Cap
-0.68
P/E
ADCT - CAPITAL EXPENDITURES
Capital Expenditures ADCT - ADC Therapeutics SA
-3.22 M
LAST VALUE
28.98%
2 YEAR CAGR
-5.42%
5 YEAR CAGR
0.00%
10 YEAR CAGR